JF
BLUE

Jump Financial’s bluebird bio BLUE Stock Holding History

Jump Financial’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,063
Closed -$64.6K – 1805
2023
Q3 		$64.6K Sell
1,063
-10,050
-90% -$706K ﹤0.01% 1726
2023
Q2 		$731K Buy
11,113
+9,908
+822% +$725K 0.03% 839
2023
Q1 		$76.6K Buy
+1,205
New +$138K ﹤0.01% 1474
2022
Q2 		– Sell
-1,982
Closed -$193K – 1632
2022
Q1 		$193K Buy
+1,982
New +$262K 0.01% 1318
2021
Q3 		– Sell
-1,444
Closed -$598K – 1117
2021
Q2 		$598K Buy
+1,444
New +$572K 0.06% 416

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return

Jump Financial's BLUE Position: Q4 2023 in Review

Jump Financial sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 1,063 shares — an estimated $64.6K sold.

Jump Financial first reported a position in BLUE in Q2 2021 and held it in 5 quarters. The position peaked at $731K in Q2 2023. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.

  • Jump Financial reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
  • Jump Financial sold 1,063 bluebird bio shares in Q4 2023, an estimated $64.6K.
  • Jump Financial first reported a position in bluebird bio in Q2 2021 and held it in 5 quarters.
  • Jump Financial's bluebird bio position peaked at $731K in Q2 2023.
  • 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.

Based on Jump Financial's 13F filing for Q4 2023, filed 7 Feb 2024.